Found 4 matching trials
Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
PHASE2The purpose of this study is to evaluate a specific cellular immune respons...
Location
Dept. of Dermatology, USZ
Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
PHASE2The purpose of this study is to evaluate a specific cellular immune respons...
Location
Ludwig Institute for Cancer Research; CHUV
Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
PHASE1The purpose of this study is to evaluate whether vaccination with a Melan-A...
Location
Dept. of Dermatology, Venerology and Allergy
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
PHASE1The purpose of this study is to monitor a specific cellular immune response...
Location
Centre Pluridisciplinaire d'Oncologie & LICR, CHUV